Therapeutic oligonucleotide metabolite identification, profiling, and quantitation

In this white paper, QPS discusses current advancements in the development of oligonucleotide analogs that can block the activity of selected genetic sequences, making the design of highly specific therapeutic treatments for various diseases possible.